Postnatal development of the cerebellum and the CNS adrenergic system is independent of norepinephrine and epinephrine

Journal of Comparative Neurology

Volumn 477, Issue 3, 2004, Pages 300-309

  Jin, Sung Ha ^a   Kim, Hyung J T ^a   Harris, D Christopher ^a   Thomas, Steven A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dopamine hydroxylase; Locus coeruleus; Mouse; Norepinephrine transporter; Purkinje cells; Tyrosine hydroxylase

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; DOPAMINE BETA MONOOXYGENASE; LIGAND; NEUROTRANSMITTER; NORADRENALIN; NORADRENALIN TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC NERVE; ADRENERGIC NERVE CELL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN DEVELOPMENT; CELL COUNT; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMITTER RELEASE; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CELL COUNT; CENTRAL NERVOUS SYSTEM; CEREBELLUM; EPINEPHRINE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NOREPINEPHRINE; TYROSINE 3-MONOOXYGENASE;

EID: 4344658485     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20263     Document Type: Article

References (54)

1. Bennett-Clarke CA, Leslie MJ, Lane RD, Rhoades RW. 1994. Effect of serotonin depletion on vibrissa-related patterns of thalamic afferents in the rat's somatosensory cortex. J Neurosci 14:7594-7607.
2. Cameron HA, Hazel TG, McKay RD. 1998. Regulation of neurogenesis by growth factors and neurotransmitters. J Neurobiol 36:287-306.
3. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P. 1996. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16:297-307.
4. Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA. 2001. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298:651-657.
5. Davies MF, Tsui JY, Flannery JA, Li X, DeLorey TM, Hoffman BB. 2003. Augmentation of the noradrenergic system in alpha-2 adrenergic receptor deficient mice: anatomical changes associated with enhanced fear memory. Brain Res 986:157-165.
6. Duncan CP, Seidler FJ, Lappi SE, Slotkin TA. 1990. Dual control of DNA synthesis by alpha- and beta-adrenergic mechanisms in normoxic and hypoxic neonatal rat brain. Brain Res Dev Brain Res 55:29-33.
7. Erskine L, McCaig CD. 1995. Growth cone neurotransmitter receptor activation modulates electric field-guided nerve growth. Dev Biol 171:330-339.
8. Felten DL, Hallman H, Jonsson G. 1982. Evidence for a neurotropic role of noradrenaline neurons in the postnatal development of rat cerebral cortex. J Neurocytol 11:119-135.
9. Frankland KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
10. Gage FH, Bjorklund A, Stenevi U. 1983. Reinnervation of the partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and noradrenergic afferents. Brain Res 268:27-37.
11. Golden GS. 1973. Prenatal development of the biogenic amine systems of the mouse brain. Dev Biol 33:300-311.
12. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R. 2002. Serotonin 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396-400.
13. Guirland C, Buck KB, Gibney JA, DiCicco-Bloom E, Zheng JQ. 2003. Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide. J Neurosci 23:2274-2283.
14. Gustafson EL, Moore RY. 1987. Noradrenaline neuron plasticity in developing rat brain: effects of neonatal 6-hydroxydopamine demonstrated by dopamine-beta-hydroxylase immunocytochemistry. Brain Res 465:143-155.
15. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, Silver J, Weeber EJ, Sweatt JD, Deneris ES. 2003. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 37:233-247.
16. Hokfelt T, Xu ZQ, Shi TJ, Holmberg K, Zhang X. 1998. Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann N Y Acad Sci 863:252-263.
17. Hume RI, Role LW, Fischbach GD. 1983. Acetylcholine release from growth cones detected with patches of acetylcholine receptor-rich membranes. Nature 305:632-634.
18. Kater SB, Mills LR. 1990. Neurotransmitter activation of second messenger pathways for the control of growth cone behaviors. Adv Exp Med Biol 265:217-225.
19. Landis DM, Sidman RL. 1978. Electron microscopic analysis of postnatal histogenesis in the cerebellar cortex of staggerer mutant mice. J Comp Neurol 179:831-863.
20. Lauder JM. 1993. Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci 16:233-240.
21. Levi-Montalcini R. 1965. Growth regulation of sympathetic nerve cells. Arch Ital Biol 103:832-846.
22. Lipton SA, Kater SB. 1989. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci 12:265-270.
23. Lovell KL. 1982. Effects of 6-hydroxydopamine-induced norepinephrine depletion on cerebellar development. Dev Neurosci 5:359-368.
24. Lundberg JM, Franco-Cereceda A, Lacroix JS, Pernow J. 1990. Neuropeptide Y and sympathetic neurotransmission. Ann N Y Acad Sci 611:166-174.
25. Luo X, Persico AM, Lauder JM. 2003. Serotonergic regulation of somatosensory cortical development: lessons from genetic mouse models. Dev Neurosci 25:173-183.
26. Morris G, Slotkin TA. 1985. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat. J Pharmacol Exp Ther 233:141-147.
27. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ. 2000. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403:86-89.
28. Murchison CF, Zhang X-Y, Zhang W-P, Ouyang M, Lee A, Thomas SA. 2004. A distinct role for norepinephrine in memory retrieval. Cell 117:131-143.
29. Nakamura S, Sakaguchi T. 1990. Development and plasticity of the locus coeruleus: a review of recent physiological and pharmacological experimentation. Prog Neurobiol 34:505-526.
30. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS. 2002. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22:7695-7711.
31. Persico AM, Mengual E, Moessner R, Hall FS, Revay RS, Sora I, Arellano J, DeFelipe J, Gimenez-Amaya JM, Conciatori M, Marino R, Baldi A, Cabib S, Pascucci T, Uhl GR, Murphy DL, Lesch KP, Keller F, Hall SF. 2001. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 21:6862-6873.
32. Portbury AL, Chandra R, Groelle M, McMillian MK, Elias A, Herlong JR, Rios M, Roffler-Tarlov S, Chikaraishi DM. 2003. Catecholamines act via a beta-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol Heart Circ Physiol 284:H2069-2077.
33. Rowe SJ, Messenger NJ, Warner AE. 1993. The role of noradrenaline in the differentiation of amphibian embryonic neurons. Development 119:1343-1357.
34. Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR, Blakely RD. 2000. Immunolocalization of the cocaine and antidepressant-sensitive 1-norepinephrine transporter. J Comp Neurol 420:211-232.
35. Sieber-Blum M. 1989. Inhibition of the adrenergic phenotype in cultured neural crest cells by norepinephrine uptake inhibitors. Dev Biol 136:372-380.
36. Sievers J, Klemm HP, Jenner S, Baumgarten HG, Berry M. 1980. Neuronal and extraneuronal effects of intracisternally administered 6-hydroxydopamine on the developing rat brain. J Neurochem 34:765-771.
37. Sklair-Tavron L, Nestler EJ, Segal M. 1994. Locus coeruleus (LC)-target interaction and cAMP in control of LC development. Brain Res Bull 35:397-402.
38. Slotkin TA, Bartolome J. 1986. Role of ornithine decarboxylase and the polyamines in nervous system development: a review. Brain Res Bull 17:307-320.
39. Swisher DA, Wilson DB. 1977. Cerebellar histogenesis in the lurcher (Lc) mutant mouse. J Comp Neurol 173:205-218.
40. Tafari AT, Thomas SA, Palmiter RD. 1997. Norepinephrine facilitates the development of the murine sweat response but is not essential. J Neurosci 17:4275-4281.
41. Tashiro A, Dunaevsky A, Blazeski R, Mason CA, Yuste R. 2003. Bidirectional regulation of hippocampal mossy fiber filopodial motility by kainate receptors: a two-step model of synaptogenesis. Neuron 38:773-784.
42. Thomas SA, Palmiter RD. 1997a. Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav Neurosci 111:579-589.
43. Thomas SA, Palmiter RD. 1997b. Impaired maternal behavior in mice lacking norepinephrine and epinephrine. Cell 91:583-592.
44. Thomas SA, Matsumoto AM, Palmiter RD. 1995. Noradrenaline is essential for mouse fetal development. Nature 374:643-646.
45. Thomas SA, Marck BT, Palmiter RD, Matsumoto AM. 1998. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70:2468-2476.
46. Weinshenker D, Szot P, Miller NS, Rust NC, Hohmann JG, Pyati U, White SS, Palmiter RD. 2001. Genetic comparison of seizure control by norepinephrine and neuropeptide Y. J Neurosci 21:7764-7769.
47. Whitaker-Azmitia PM. 2001. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56:479-485.
48. Wood TL, Kobayashi Y, Frantz G, Varghese S, Christakos S, Tobin AJ. 1988. Molecular cloning of mammalian 28,000 Mr vitamin D-dependent calcium binding protein (calbindin-D28K): expression of calbindin-D28K RNAs in rodent brain and kidney. DNA 7:585-593.
49. Young SH, Poo MM. 1983. Spontaneous release of transmitter from growth cones of embryonic neurones. Nature 305:634-637.
50. Zhang JM, Dix J, Langtimm-Sedlak CJ, Trusk T, Schroeder B, Hoffmann R, Strosberg AD, Winslow JW, Sieber-Blum M. 1997. Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine. J Neurobiol 32:262-280.
51. Zhang W-P, Ouyang M, Thomas SA. 2004. Potency of catecholamines and other L-tyrosine derivatives at the cloned mouse adrenergic receptors. Neuropharmacology 47:438-449.
52. Zheng JQ, Felder M, Connor JA, Poo MM. 1994. Turning of nerve growth cones induced by neurotransmitters. Nature 368:140-144.
53. Zhou QY, Palmiter RD. 1995. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83:1197-1209.
54. Zhou QY, Quaife CJ, Palmiter RD. 1995. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374:640-643.